Skip to main content
Clinical Trials/NCT03388320
NCT03388320
Unknown
Not Applicable

Using Addiction Comprehensive Health Enhancement Support System (ACHESS) in an Alcoholic Liver Disease Population

New York Presbyterian Hospital1 site in 1 country30 target enrollmentApril 24, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Liver Diseases, Alcoholic
Sponsor
New York Presbyterian Hospital
Enrollment
30
Locations
1
Primary Endpoint
Rates of recidivism
Last Updated
7 years ago

Overview

Brief Summary

This is a pilot study examining whether an evidence-based recovery support smartphone application, the Addiction Comprehensive Health Enhancement Support System (A-CHESS), can decrease alcohol recidivism in a previously unstudied group of patients with alcoholic liver disease (ALD).

Detailed Description

A-CHESS is a smartphone application developed by the University of Wisconsin-Madison based on self-determination theory, with a previous randomized clinical trial showing that use of the app resulted in significantly fewer risky drinking days in patients leaving treatment for alcohol-use disorders. The application is downloaded to the participant's smartphone, and provides ongoing access to peer support and educational materials, monitoring of the risk of relapse, and delivery of reminders and encouragements to the patient. The application also has a survey platform to assess and reassess the participants' most recent alcohol consumption, quality of life, and experience using the application. We anticipate that use of the A-CHESS app will result in decreased drinking and improved abstinence, identifying a potential intervention to offer patients with ALD to improve their mortality, liver disease, and likelihood of liver transplant candidacy status.

Registry
clinicaltrials.gov
Start Date
April 24, 2018
End Date
December 1, 2021
Last Updated
7 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Nicole T Shen

Principal Investigator

New York Presbyterian Hospital

Eligibility Criteria

Inclusion Criteria

  • Alcoholic liver disease
  • Followed or seen at New York Presbyterian Hospital / Weill Cornell Medical Center
  • English speaking
  • Access to a smartphone

Exclusion Criteria

  • Unable to consent
  • Primary language other than English
  • No access to a smartphone

Outcomes

Primary Outcomes

Rates of recidivism

Time Frame: 6 months

Rates of recidivism in this population using A-CHESS will be compared to historical control rates

Secondary Outcomes

  • Use of A-CHESS(6 months)

Study Sites (1)

Loading locations...

Similar Trials